Nanoformulated antibiotics: The next step for pathogenic bacteria control

Current Medicinal Chemistry

Volumn 20, Issue 10, 2013, Pages 1232-1240

  Saúde, Amanda Caroline Marques ^a,b   Cherobim, Mariana Dornelles ^a,b   Amaral, André Corrêa ^a,b   Dias, Simoní Campos ^a,b   Franco, Octávio Luiz ^a,b  

^a Centro de Analises Proteomicas e Bioquimicas   (Brazil)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

Antibiotics; Antimicrobial peptides; Bacteria; Infectious diseases; Nanoparticles

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; DRUG CARRIER; GENTAMICIN; LEVOFLOXACIN; NANOMATERIAL; NANOPARTICLE; NISIN; P10 PEPTIDE; PENICILLIN DERIVATIVE; PEPTIDE; POLYMER; RIFAMPICIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; ATOMIC FORCE MICROSCOPY; BIOTECHNOLOGY; CARDIOVASCULAR SYSTEM; CONTROLLED RELEASE FORMULATION; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG SOLUBILITY; ELECTRON MICROSCOPY; ENCAPSULATION; GENOTOXICITY; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOMODULATION; LIGHT SCATTERING; MORPHOLOGY; NANOBIOTECHNOLOGY; NONHUMAN;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; BACTERIAL INFECTIONS; DRUG CARRIERS; DRUG STABILITY; HUMANS; NANOSTRUCTURES; NANOTECHNOLOGY; POLYMERS;

EID: 84877947117     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867311320100004     Document Type: Article

References (45)

1. Zanetti-Ramos B. G. Creczynski-Pasa T. B. O desenvolvimento da nanotecnologia: cenario mundial e nacional de investimentos. Revista Brasileira de Ciecncias Farmacecuticas 2008 89(2) 95-101.
2. Kurek A. Grudniak A. M. Kraczkiewicz-Dowjat A. Wolska K. I. New antibacterial therapeutics and strategies. Polish Journal of Microbiology 2011 60 3-12.
3. Wright D. M. Saracevic Z. S. Kyle N. H. Motskin M. Skepper J. N. The mesoporosity of microparticles spray dried from trehalose and nanoparticle hydroxyapatite depends on the ratio of nanoparticles to sugar and nanoparticle surface charge. Journal of Materials Science: Materials in Medicine 2010 21 (1) 189-206.
4. Khan S. Mukherjee A. Chandrasekaran N. Silver nanoparticles tolerant bacteria from sewage environment. Journal of Environmental Sciences 2011 23 (2) 346-352.
5. Pinto Reis C. Neufeld R. J. Ribeiro A. J. Veiga F. Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine 2006 2 (1) 8-21.
6. Feng Q. L. Wu J. Chen G. Q. Cui F. Z. Kim T. N. Kim J. O. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. Journal of Biomedical Materials Research 2000 52 (4) 662-668.
7. Chicea D. Nanoparticles and nanoparticle aggregates sizing by DLS and AFM. Journal of Optoelectronics and Advanced Materials 2010 4 (9) 1310 -1315.
8. Nidhin M. Indumathy R. Sreeram K. J. Uni Nai B. Synthesis of iron oxide nanoparticles of narrow size distribution on polysaccharide templates Bulletin of Material Science 2008 31 (1) 93-96.
9. Farboud E. S. Nasrollahi S. A. Tabbakhi Z. Novel formulation and evaluation of a Q10-loaded solid lipid nanoparticle cream: in vitro and in vivo studies. International Journal of Nanomedicine 2011 6 611-617.
10. Nederberg F. Zhang Y. Tan J. P. Xu K. Wang H. Yang C. Gao S. Guo X. D. Fukushima K. Li L. Hedrick J. L. Yang Y. Y. Biodegradable nanostructures with selective lysis of microbial membranes. Nature Chemistry 2011 3 (5) 409-414.
11. Brannon -Peppas L. Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug-delivery. International Journal of Pharmaceutics 1995 116 (1) 1-9.
12. Urban P. Valle-Delgado J. J. Moles E. Marques J. Diez C. Fernandes-Busquets X. Nanotools for delivery of antimicrobial peptides. Current Drug Targets 2012 13(9):1158-1172.
13. Xie J. Lee S. Chen X. Nanoparticle-based theranostic agents. Advanced drug delivery reviews 2010 62 (11) 1064-1079.
14. Malvern Dynamic Light Scattering: an introduction in 30 minutes. In DLS technical note Technical note (MRK656-01) ed. Marlvern Ed. 2010.
15. Schaffazick S. R. Guterres S. S. Caracterizacao e estabilidade fisicoquimica de sistemas polimericos nanoparticulados para administracao de farmacos. Quimica Nova 2003 26 (5) 726-737.
16. Medeiros K. A. Desenvolvimento e testes in vitro de nanoparticulas de quitosana para liberacao controlada de peptideos antitumorais. 2011 Mastre thesis University of Brasilia.
17. Leiviska T. Ramo J. Investigation of multimodal zeta potential and size distribution in chemical pulp process water. Water Science Technology 2007 56 (11) 123-129. (Pubitemid 351166338)
18. Shemetov A. A. Nabiev I. Sukhanova A. Molecular interaction of proteins and peptides with nanoparticles. ACS Nano 2012 6 (6) 4585-4602.
19. Qiu L. Y. Bae Y. H. Polymer architecture and drug delivery. Pharmaceutical research 2006 23 (1) 1-30. (Pubitemid 43214657)
20. Toti U. S. Guru B. R. Hali M. McPharlin C. M. Targeted delivery of antibiotics to intracellular clamydial infections using PLGA nanoparticles. Biomaterials 2011 1-8.
21. Muthu M. S. Nanoparticles based on PLGA and its co-polymer: An overview. Asian Journal of Pharmaceutical Science 2009 3 (4) 266-273.
22. Amaral A. C. Bocca A. L. Ribeiro A. M. Nunes J. Peixoto D. L. Simioni A. R. Primo F. L. Lacava Z. G. Bentes R. Titzede-Almeida R. Tedesco A. C. Morais P. C. Felipe M. S. Amphotericin B in poly(lactic-co-glycolic acid) (PLGA) and dimercaptosuccinic acid (DMSA) nanoparticles against paracoccidioidomycosis. Journal of Antimicrobial Chemotherapy 2009 63 (3) 526-533.
23. Dhiman N. Dutta M. Khuller G. K. Poly (DL-lactide-coglycolide) based delivery systems for vaccines and drugs. Indian Journal of Experimental Biology 2000 38 (8) 746-752.
24. Amaral A. C. Marques A. F. Munoz J. E. Bocca A. L. Simioni A. R. Tedesco A. C. Morais P. C. Travassos L. R. Taborda C. P. Felipe M. S. Poly(lactic acid-glycolic acid) nanoparticles markedly improve immunological protection provided by peptide P10 against murine paracoccidioidomycosis. British Journal of Pharmacology 2010 159 (5) 1126-1132.
25. Ham A. S. Cost M. R. Sassi A. B. Dezzutti C. S. Rohan L. C. Targeted delivery of PSC-RANTES for HIV-1 prevention using biodegradable nanoparticles. Pharmaceutical Research 2009 26 (3) 502-511.
26. Turos E. Shim J. Y. Wang Y. Greenhalgh K. Reddy G. S. Dickey S. Lim D. V. Antibiotic-conjugated polyacrylate nanoparticles: new opportunities for development of anti-MRSA agents. Bioorganic Medicinal Chemistry Letters 2007 17 (1) 53-56. (Pubitemid 46001585)
27. Kho K. Cheow W. S. Lie R. H. Hadinoto K. Aqueous redispersibility of spray-dried antibiotic-loaded polycaprolactone nanoparticle aggregates for inhaled anti-biofilm therapy. Powder Technology 2010 203 432-439.
28. Turos E. Reddy G. S. Greenhalgh K. Ramaraju P. Abeylath S. C. Jang S. Dickey S. Lim D. V. Penicillin-bound polyacrylate nanoparticles: restoring the activity of beta-lactam antibiotics against MRSA. Bioorganic Medicinal Chemistry Letters 2007 17 (12) 3468-3472. (Pubitemid 46830890)
29. Jiang J. L. Li Y. F. Fang T. L. Zhou J. Li X. L. Wang Y. C. Dong J. Vancomycin-loaded nano-hydroxyapatite pellets to treat MRSA-induced chronic osteomyelitis with bone defect in rabbits. Inflamatory Research 2012 61 207-215.
30. Zhu X. Eibl O. Berthold C. Scheideler L. Geis-Gerstorfer J. Structural characterization of nanocrystalline hydroxyapatite and adhesion of pre-osteoblast cells. Nanotechnology 2006 17 2711-2721. (Pubitemid 43814919)
31. Fontana G. Licciardi M. Mansueto S. Schillaci D. Giammona G. Amoxicillin-loaded polyethylcyanoacrylate nanoparticles: influence of PEG coating on the particle size drug release rate and phagocytic uptake. Biomaterials 2001 22 (21) 2857-2865. (Pubitemid 32739242)
32. Bender E. A. Adorne M. D. Colome L. M. Abdalla D. S. Guterres S. S. Pohlmann A. R. Hemocompatibility of poly(varepsilon-caprolactone) lipid-core nanocapsules stabilized with polysorbate 80-lecithin and uncoated or coated with chitosan. International Journal of Pharmaceutics 2012 426 (1-2) 271-279.
33. Cheow W. S. Chang M. W. Hadinoto K. Antibacterial efficacy of inhalable levofloxacin-loaded polymeric nanoparticles against E. coli biofilm cells: the effect of antibiotic release profile. Pharmaceutical Research 2010 27 (8) 1597-1609.
34. Ban M. Langonne I. Huguet N. Goutet M. Effect of submicron and nano-iron oxide particles on pulmonary immunity in mice. Toxicology Letters 2012 210 (3) 267-275.
35. Helson R. Olszewska W. Singh M. Megede J. Z. Melero J. A. O'Hagan D. Openshaw P. J. Polylactide-co-glycolide (PLG) microparticles modify the immune response to DNA vaccination. Vaccine 2008 26 (6) 753-761.
36. Clawson C. Huang C. T. Futalan D. Seible D. M. Saenz R. Larsson M. Ma W. Minev B. Zhang F. Ozkan M. Ozkan C. Esener S. Messmer D. Delivery of a peptide via poly(DL-lacticco-glycolic) acid nanoparticles enchances its dendritic cellstimulatory capacity. Nanomedicine 2012 5 651-661.
37. Bi L. Yang L. Bhunia A. K. Yao Y. Carbohydrate nanoparticle-mediated colloidal assembly for prolonged efficacy of bacteriocin against food pathogen. Biotechnology and Bioengineering 2011 108 (7) 1529-1536.
38. Liu L. Xu K. Wang H. Tan J. P. Fan W. Venkatraman S. S. Li L. Yang Y. Y. Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent. . Nature Nanotechnology 2009 4 457-463.
39. Snyder R. D. Green J. W. A review of the genotoxicity of marketed pharmaceuticals. Mutation Research 2001 488 (2) 151-169. (Pubitemid 32436429)
40. Fenech M. The in vitro micronucleus technique. Mutation Research 2000 455 81-95.
41. Demsia G. Vlastos D. Goumenou M. Matthopoulos D. P. Assessment of the genotoxicity of imidacloprid and metalaxyl incultures human lymphocytes and rat bone marrow. Mutation Research 2007 634 32-39. (Pubitemid 47634012)
42. Smith D. F. MacGregor J. T. Hiatt R. A. Hooper N. K. Wehr C. M. Peters B. Goldman L. R. Yuan L. A. Smith P. A. Becker C. E. Micronucleated erythrocytes as an index of cytogenetic damage in humans: demographic and dietary factors associated with micronucleated erythrocytes in splenectomized subjetcs. Cancer Research 1990 50 5049-5054. (Pubitemid 20257934)
43. Gorth D. J. Rand D. M. Webster T. J. Silver nanoparticles toxicity in Drosophila: size does matter. International Journal of Nanomedicine 2011 6 343-350.
44. Vecchio G. Galeone A. Brunetti V. Maiorano G. Rizzello L. Sabella S. Cingolani R. Pompa P. P. Mutagenic effects of gold nanoparticles induce aberrant phenotypes in Drosophila melanogaster. Nanomedicine 2012 8 (1) 1-7.
45. Lecaroz C. Campanero M. A. Gamazo C. Blanco-Prieto M. J. Determination of gentamicin in different matrices by a new sensitive high-performance liquid chromatography-mass spectrometric method. Journal of Antimicrobial Agents and Chemotherapies 2006 58 (3) 557-5563.